|
OMIM |
Link |
Information gain |
01 |
|
G6PD
|
[NCBI]
|
0.00685884
|
|
|
stomatocytosis i
|
[NCBI]
|
0.00420476
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.00414065
|
|
|
red cell phospholipid defect with hemolysis
|
[NCBI]
|
0.00403627
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
0.00379107
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
0.00376789
|
|
|
HBFQTL2
|
[NCBI]
|
0.0037319
|
|
|
CDAN2
|
[NCBI]
|
0.00334863
|
|
|
DHS
|
[NCBI]
|
0.00326867
|
|
|
CAT
|
[NCBI]
|
0.00300877
|
|
|
pentosuria
|
[NCBI]
|
0.00297362
|
|
|
CDAN3
|
[NCBI]
|
0.00273718
|
|
|
wernicke-korsakoff syndrome
|
[NCBI]
|
0.00273718
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.00239592
|
|
|
CTS1
|
[NCBI]
|
0.00237154
|
|
|
uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to
|
[NCBI]
|
0.00214493
|
|
|
scott syndrome
|
[NCBI]
|
0.00211799
|
|
|
MCDU
|
[NCBI]
|
0.00197955
|
|
|
ACHE
|
[NCBI]
|
0.00147265
|
|
|
glycogen storage disease vii
|
[NCBI]
|
0.00140511
|
|
|
ADA
|
[NCBI]
|
0.00140105
|
|
|
HBFQTL3
|
[NCBI]
|
0.00136297
|
|
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.00136297
|
|
|
galactosemia
|
[NCBI]
|
0.00132804
|
|
|
ESD
|
[NCBI]
|
0.00121575
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
0.00114302
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
0.00107098
|
|
|
adenosine deaminase, elevated, hemolytic anemia due to
|
[NCBI]
|
0.00107098
|
|
|
HBB
|
[NCBI]
|
0.00100927
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.0010034
|
|
|
argininemia
|
[NCBI]
|
0.000999207
|
|
|
adenosine triphosphatase deficiency, anemia due to
|
[NCBI]
|
0.000988354
|
|
|
pseudohyperkalemia, familial, 2, due to red cell leak
|
[NCBI]
|
0.000988354
|
|
|
6-@phosphogluconolactonase deficiency
|
[NCBI]
|
0.000988354
|
|
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.000988354
|
|
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.000988354
|
|
|
EPO
|
[NCBI]
|
0.000925883
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
0.000881993
|
|
|
COMT
|
[NCBI]
|
0.000875084
|
|
|
ACP1
|
[NCBI]
|
0.000819227
|
|
|
glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
[NCBI]
|
0.000747753
|
|
|
hypertension, essential
|
[NCBI]
|
0.00072045
|
|
|
EL1
|
[NCBI]
|
0.000702843
|
|
|
stomatocytosis ii
|
[NCBI]
|
0.000680098
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
0.000680098
|
|
|
EGF
|
[NCBI]
|
0.000677283
|
|
|
VEGF
|
[NCBI]
|
0.000629502
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
0.000594621
|
|
|
GPI
|
[NCBI]
|
0.000581221
|
|
|
HBFQTL4
|
[NCBI]
|
0.000565454
|
|
|
transient erythroblastopenia of childhood
|
[NCBI]
|
0.000565454
|
|
|
SLC4A1
|
[NCBI]
|
0.000565285
|
|
|
NGFB
|
[NCBI]
|
0.000538577
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
0.000528367
|
|
|
galactokinase deficiency
|
[NCBI]
|
0.000524682
|
|
|
PKLR
|
[NCBI]
|
0.000523454
|
|
|
TPMT
|
[NCBI]
|
0.000504986
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
0.000501055
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
0.000501055
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000491965
|
|
|
porphyria cutanea tarda, type i
|
[NCBI]
|
0.000476823
|
|
|
erythrocyte lactate transporter defect
|
[NCBI]
|
0.000475624
|
|
|
ALAD
|
[NCBI]
|
0.000472061
|
|
|
TPI1
|
[NCBI]
|
0.000465273
|
|
|
HS
|
[NCBI]
|
0.000463412
|
|
|
sickle cell anemia
|
[NCBI]
|
0.000449247
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
0.000445954
|
|
|
reticular dysgenesia
|
[NCBI]
|
0.000438022
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000438022
|
|
|
GPX1
|
[NCBI]
|
0.000437759
|
|
|
NP
|
[NCBI]
|
0.00042597
|
|
|
HBFQTL1
|
[NCBI]
|
0.000421161
|
|
|
GSR
|
[NCBI]
|
0.000391261
|
|
|
HPRT1
|
[NCBI]
|
0.000387589
|
|
|
NPY
|
[NCBI]
|
0.000381488
|
|
|
gout, hprt-related
|
[NCBI]
|
0.000368276
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
0.000368276
|
|
|
CA1
|
[NCBI]
|
0.000367967
|
|
|
splenic hypoplasia
|
[NCBI]
|
0.000360767
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
0.000356663
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
0.000339948
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
0.000339948
|
|
|
PGM1
|
[NCBI]
|
0.000335617
|
|
|
IGES
|
[NCBI]
|
0.00033135
|
|
|
SLE
|
[NCBI]
|
0.000322912
|
|
|
TNF
|
[NCBI]
|
0.000313628
|
|
|
HMBS
|
[NCBI]
|
0.000312711
|
|
|
PRL
|
[NCBI]
|
0.000305062
|
|
|
APRT
|
[NCBI]
|
0.000296982
|
|
|
AK1
|
[NCBI]
|
0.000293045
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
0.000287512
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
0.000274336
|
|
|
RA
|
[NCBI]
|
0.000266721
|
|
|
VIP
|
[NCBI]
|
0.000266388
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
0.000262642
|
|
|
ABL
|
[NCBI]
|
0.000257742
|
|
|
CCK
|
[NCBI]
|
0.000254595
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
0.000252135
|
|
|
GFAP
|
[NCBI]
|
0.000247491
|
|
|
diphosphoglycerate mutase deficiency of erythrocyte
|
[NCBI]
|
0.000243018
|
|
|
EGFR
|
[NCBI]
|
0.000242728
|
|
|
lithium transport
|
[NCBI]
|
0.000237739
|
|
|
favism, susceptibility to
|
[NCBI]
|
0.000237739
|
|
|
adenosine triphosphate, elevated, of erythrocytes
|
[NCBI]
|
0.000237739
|
|
|
KN
|
[NCBI]
|
0.000237739
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
0.000237739
|
|
|
aromatic alpha-keto acid reductase
|
[NCBI]
|
0.000237739
|
|
|
CP
|
[NCBI]
|
0.000226874
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
0.000223349
|
|
|
SPTA1
|
[NCBI]
|
0.00022331
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
0.000222939
|
|
|
PCNA
|
[NCBI]
|
0.000221045
|
|
|
HPP
|
[NCBI]
|
0.000208857
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
0.000208857
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
0.000208393
|
|
|
DBA
|
[NCBI]
|
0.000207415
|
|
|
MG
|
[NCBI]
|
0.000202889
|
|
|
OPTB3
|
[NCBI]
|
0.00019693
|
|
|
TRMA
|
[NCBI]
|
0.00019693
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
0.00019693
|
|
|
PGD
|
[NCBI]
|
0.000187322
|
|
|
NT5C3
|
[NCBI]
|
0.0001869
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
0.000184066
|
|
|
ovalocytosis, hereditary hemolytic
|
[NCBI]
|
0.000184066
|
|
|
raph blood group system
|
[NCBI]
|
0.000184066
|
|
|
behcet syndrome
|
[NCBI]
|
0.000179026
|
|
|
HBA1
|
[NCBI]
|
0.000178878
|
|
|
CR1
|
[NCBI]
|
0.000175255
|
|
|
AVP
|
[NCBI]
|
0.000175172
|
|
|
AR
|
[NCBI]
|
0.000171002
|
|
|
GALT
|
[NCBI]
|
0.000167974
|
|
|
HK1
|
[NCBI]
|
0.000167477
|
|
|
AD
|
[NCBI]
|
0.000165832
|
|
|
CA2
|
[NCBI]
|
0.000165434
|
|
|
BCHE
|
[NCBI]
|
0.000163673
|
|
|
AKR1B1
|
[NCBI]
|
0.00016148
|
|
|
pseudohyperkalemia cardiff
|
[NCBI]
|
0.000160043
|
|
|
CJD
|
[NCBI]
|
0.000159912
|
|
|
CHAC
|
[NCBI]
|
0.0001567
|
|
|
CHAT
|
[NCBI]
|
0.000155819
|
|
|
PEPD
|
[NCBI]
|
0.000152944
|
|
|
CEACAM5
|
[NCBI]
|
0.000150659
|
|
|
CMPK1
|
[NCBI]
|
0.000148844
|
|
|
PEPA
|
[NCBI]
|
0.000148844
|
|
|
GLO1
|
[NCBI]
|
0.000146709
|
|
|
AHO
|
[NCBI]
|
0.000145959
|
|
|
Ii
|
[NCBI]
|
0.000143687
|
|
|
cryohydrocytosis, stomatin-deficient, with mental retardation, seizures, cataracts, and massive hepatosplenomegaly
|
[NCBI]
|
0.000143687
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
0.000143687
|
|
|
PGK1
|
[NCBI]
|
0.000141545
|
|
|
MN
|
[NCBI]
|
0.000137986
|
|
|
SOD1
|
[NCBI]
|
0.000136933
|
|
|
CD59
|
[NCBI]
|
0.00013537
|
|
|
MBP
|
[NCBI]
|
0.000134744
|
|
|
FY
|
[NCBI]
|
0.000132877
|
|
|
RHN
|
[NCBI]
|
0.000131252
|
|
|
phosphorylase kinase deficiency of liver and muscle, autosomal recessive
|
[NCBI]
|
0.000131252
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
0.000126037
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
0.000121233
|
|
|
thrombocythemia, essential
|
[NCBI]
|
0.000120372
|
|
|
immunoerythromyeloid hypoplasia
|
[NCBI]
|
0.000118851
|
|
|
hemopoietic proliferation
|
[NCBI]
|
0.000118851
|
|
|
folate level in erythrocytes
|
[NCBI]
|
0.000118851
|
|
|
gil blood group
|
[NCBI]
|
0.000118851
|
|
|
hla modifier
|
[NCBI]
|
0.000118851
|
|
|
CKBE
|
[NCBI]
|
0.000118851
|
|
|
transaldolase deficiency
|
[NCBI]
|
0.000118851
|
|
|
nephropathy with pretibial epidermolysis bullosa and deafness
|
[NCBI]
|
0.000118851
|
|
|
methemoglobin reductase deficiency
|
[NCBI]
|
0.000118851
|
|
|
blood group--abh antigen, type 2
|
[NCBI]
|
0.000118851
|
|
|
blood group--en
|
[NCBI]
|
0.000118851
|
|
|
inosine phosphorylase deficiency, immune defect due to
|
[NCBI]
|
0.000118851
|
|
|
blood group--private systems
|
[NCBI]
|
0.000118851
|
|
|
orotic aciduria ii
|
[NCBI]
|
0.000118851
|
|
|
acetophenetidin sensitivity
|
[NCBI]
|
0.000118851
|
|
|
thyroid hormone plasma membrane transport defect
|
[NCBI]
|
0.000118851
|
|
|
anemia, nonspherocytic hemolytic, associated with abnormality of red cell membrane
|
[NCBI]
|
0.000118851
|
|
|
butyrylesterase 1
|
[NCBI]
|
0.000118851
|
|
|
aicar transformylase/imp cyclohydrolase, deficiency of
|
[NCBI]
|
0.000118851
|
|
|
hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase
|
[NCBI]
|
0.000118851
|
|
|
convulsive disorder, familial, with prenatal or early onset
|
[NCBI]
|
0.000118851
|
|
|
insulin receptors, familial increase in
|
[NCBI]
|
0.000118851
|
|
|
KLK3
|
[NCBI]
|
0.000118448
|
|
|
PD
|
[NCBI]
|
0.000115492
|
|
|
GPT
|
[NCBI]
|
0.00011367
|
|
|
Ge
|
[NCBI]
|
0.000111628
|
|
|
PDXK
|
[NCBI]
|
0.000111601
|
|
|
LPL
|
[NCBI]
|
0.000103792
|
|
|
MDH1
|
[NCBI]
|
0.000101736
|
|
|
LDHA
|
[NCBI]
|
0.000100256
|
|
|
MAFD2
|
[NCBI]
|
0.000100188
|
|
|
LNS
|
[NCBI]
|
9.85148e-05
|
|
|
SPTB
|
[NCBI]
|
9.78577e-05
|
|
|
CD47
|
[NCBI]
|
9.60981e-05
|
|
|
PGP
|
[NCBI]
|
9.55964e-05
|
|
|
PRPS1
|
[NCBI]
|
9.41319e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
9.34381e-05
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
8.93633e-05
|
|
|
liddle syndrome
|
[NCBI]
|
8.88473e-05
|
|
|
EPB41
|
[NCBI]
|
8.79422e-05
|
|
|
SLC2A1
|
[NCBI]
|
8.79422e-05
|
|
|
PTK2
|
[NCBI]
|
8.71304e-05
|
|
|
GALK1
|
[NCBI]
|
8.52318e-05
|
|
|
ALDOA
|
[NCBI]
|
8.52318e-05
|
|
|
PCMT1
|
[NCBI]
|
8.50383e-05
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
8.43338e-05
|
|
|
CF
|
[NCBI]
|
8.4012e-05
|
|
|
TNFSF6
|
[NCBI]
|
8.08278e-05
|
|
|
HBA2
|
[NCBI]
|
8.03982e-05
|
|
|
bernard-soulier syndrome, benign autosomal dominant
|
[NCBI]
|
8.0004e-05
|
|
|
heinz body anemias
|
[NCBI]
|
8.0004e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
8.0004e-05
|
|
|
GUK2
|
[NCBI]
|
8.0004e-05
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
8.0004e-05
|
|
|
AMPD3
|
[NCBI]
|
7.7335e-05
|
|
|
TSTA3
|
[NCBI]
|
7.7335e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
7.64406e-05
|
|
|
porphyria variegata
|
[NCBI]
|
7.62559e-05
|
|
|
KLF1
|
[NCBI]
|
7.34867e-05
|
|
|
GMPR
|
[NCBI]
|
7.33342e-05
|
|
|
APOE
|
[NCBI]
|
7.10438e-05
|
|
|
JK
|
[NCBI]
|
7.03487e-05
|
|
|
NPPA
|
[NCBI]
|
6.8891e-05
|
|
|
PTH
|
[NCBI]
|
6.83679e-05
|
|
|
CGD
|
[NCBI]
|
6.82846e-05
|
|
|
ARG1
|
[NCBI]
|
6.76649e-05
|
|
|
ALPS
|
[NCBI]
|
6.70824e-05
|
|
|
CRC
|
[NCBI]
|
6.5718e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
6.56091e-05
|
|
|
SW
|
[NCBI]
|
6.56091e-05
|
|
|
YT
|
[NCBI]
|
6.56091e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
6.56091e-05
|
|
|
ADCP1
|
[NCBI]
|
6.56091e-05
|
|
|
ARTS
|
[NCBI]
|
6.56091e-05
|
|
|
dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema
|
[NCBI]
|
6.56091e-05
|
|
|
blood group--froese
|
[NCBI]
|
6.56091e-05
|
|
|
CMAH
|
[NCBI]
|
6.56091e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
6.56091e-05
|
|
|
MTHFR
|
[NCBI]
|
6.52284e-05
|
|
|
F3
|
[NCBI]
|
6.42801e-05
|
|
|
ADD2
|
[NCBI]
|
6.37748e-05
|
|
|
HAGH
|
[NCBI]
|
6.37748e-05
|
|
|
PPA1
|
[NCBI]
|
6.37748e-05
|
|
|
RP
|
[NCBI]
|
6.35879e-05
|
|
|
HNMT
|
[NCBI]
|
6.33307e-05
|
|
|
PFKM
|
[NCBI]
|
6.29985e-05
|
|
|
PFKL
|
[NCBI]
|
6.29985e-05
|
|
|
GUK3
|
[NCBI]
|
6.22894e-05
|
|
|
ACYP1
|
[NCBI]
|
6.22894e-05
|
|
|
ERAF
|
[NCBI]
|
5.93951e-05
|
|
|
AFP
|
[NCBI]
|
5.84291e-05
|
|
|
LCAT
|
[NCBI]
|
5.82753e-05
|
|
|
ABO
|
[NCBI]
|
5.72656e-05
|
|
|
GRTH
|
[NCBI]
|
5.64118e-05
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
5.64118e-05
|
|
|
spherocytosis, autosomal recessive
|
[NCBI]
|
5.64118e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
5.64118e-05
|
|
|
VLDLRCH
|
[NCBI]
|
5.64118e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
5.64118e-05
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
5.64118e-05
|
|
|
ITPA
|
[NCBI]
|
5.58026e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.51175e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
5.32824e-05
|
|
|
PPARA
|
[NCBI]
|
5.30816e-05
|
|
|
GALE
|
[NCBI]
|
5.27577e-05
|
|
|
TST
|
[NCBI]
|
5.27577e-05
|
|
|
GSS
|
[NCBI]
|
5.27577e-05
|
|
|
C3
|
[NCBI]
|
5.25808e-05
|
|
|
GNRH1
|
[NCBI]
|
5.23826e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
5.2146e-05
|
|
|
AHR
|
[NCBI]
|
5.17717e-05
|
|
|
TPT1
|
[NCBI]
|
5.14415e-05
|
|
|
ADD1
|
[NCBI]
|
5.01169e-05
|
|
|
FUT1
|
[NCBI]
|
5.01169e-05
|
|
|
Ss
|
[NCBI]
|
5.01169e-05
|
|
|
TF
|
[NCBI]
|
4.99766e-05
|
|
|
LDHB
|
[NCBI]
|
4.98797e-05
|
|
|
RCDP2
|
[NCBI]
|
4.9683e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
4.9683e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
4.9683e-05
|
|
|
atransferrinemia
|
[NCBI]
|
4.9683e-05
|
|
|
anemia, microcytic
|
[NCBI]
|
4.9683e-05
|
|
|
PSMC6
|
[NCBI]
|
4.86334e-05
|
|
|
GSTT1
|
[NCBI]
|
4.86334e-05
|
|
|
SIGLEC8
|
[NCBI]
|
4.86334e-05
|
|
|
ADD3
|
[NCBI]
|
4.86334e-05
|
|
|
TG
|
[NCBI]
|
4.63874e-05
|
|
|
VDR
|
[NCBI]
|
4.61767e-05
|
|
|
CFI
|
[NCBI]
|
4.57041e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
4.47479e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
4.44081e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
4.44081e-05
|
|
|
GGM
|
[NCBI]
|
4.44081e-05
|
|
|
HOMG3
|
[NCBI]
|
4.44081e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
4.44081e-05
|
|
|
EPD
|
[NCBI]
|
4.44081e-05
|
|
|
XRN
|
[NCBI]
|
4.44081e-05
|
|
|
SLC40A1
|
[NCBI]
|
4.41915e-05
|
|
|
MDD
|
[NCBI]
|
4.40423e-05
|
|
|
IDH1
|
[NCBI]
|
4.38221e-05
|
|
|
ALDH1A1
|
[NCBI]
|
4.31982e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
4.21071e-05
|
|
|
GOT1
|
[NCBI]
|
4.21071e-05
|
|
|
CD
|
[NCBI]
|
4.01734e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
4.0094e-05
|
|
|
AQP1
|
[NCBI]
|
3.96e-05
|
|
|
CFD
|
[NCBI]
|
3.83431e-05
|
|
|
HBD
|
[NCBI]
|
3.83431e-05
|
|
|
CD99
|
[NCBI]
|
3.77291e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
3.64627e-05
|
|
|
hypouricemia, renal
|
[NCBI]
|
3.64627e-05
|
|
|
erythroleukemia, familial
|
[NCBI]
|
3.64627e-05
|
|
|
WAS
|
[NCBI]
|
3.55138e-05
|
|
|
SLC4A3
|
[NCBI]
|
3.51693e-05
|
|
|
ANK2
|
[NCBI]
|
3.51693e-05
|
|
|
PON1
|
[NCBI]
|
3.43951e-05
|
|
|
XK
|
[NCBI]
|
3.41841e-05
|
|
|
RP11
|
[NCBI]
|
3.33419e-05
|
|
|
homocysteinemia
|
[NCBI]
|
3.33419e-05
|
|
|
blood group, p system
|
[NCBI]
|
3.33419e-05
|
|
|
RHCE
|
[NCBI]
|
3.31402e-05
|
|
|
GSTP1
|
[NCBI]
|
3.31402e-05
|
|
|
SLC19A2
|
[NCBI]
|
3.26092e-05
|
|
|
DIA2
|
[NCBI]
|
3.11434e-05
|
|
|
glutaredoxin 5
|
[NCBI]
|
3.11434e-05
|
|
|
PSMD4
|
[NCBI]
|
3.11434e-05
|
|
|
monophosphoglycerate mutase
|
[NCBI]
|
3.11434e-05
|
|
|
EIF4EL2
|
[NCBI]
|
3.11434e-05
|
|
|
PSMD11
|
[NCBI]
|
3.11434e-05
|
|
|
ATIC
|
[NCBI]
|
3.11434e-05
|
|
|
hemoglobin mu
|
[NCBI]
|
3.11434e-05
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
3.11434e-05
|
|
|
PSMD12
|
[NCBI]
|
3.11434e-05
|
|
|
PGM2L1
|
[NCBI]
|
3.11434e-05
|
|
|
TTP
|
[NCBI]
|
3.06175e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
3.06175e-05
|
|
|
CMD3B
|
[NCBI]
|
3.06175e-05
|
|
|
PFKP
|
[NCBI]
|
3.04669e-05
|
|
|
methemoglobinemia due to deficiency of cytochrome b5
|
[NCBI]
|
3.04669e-05
|
|
|
RHAG
|
[NCBI]
|
3.04669e-05
|
|
|
PGAM1
|
[NCBI]
|
3.04669e-05
|
|
|
PRDX1
|
[NCBI]
|
3.04669e-05
|
|
|
CD55
|
[NCBI]
|
3.04669e-05
|
|
|
KEL
|
[NCBI]
|
3.04669e-05
|
|
|
CFTR
|
[NCBI]
|
2.94717e-05
|
|
|
PEPC
|
[NCBI]
|
2.86279e-05
|
|
|
SFRS1
|
[NCBI]
|
2.86279e-05
|
|
|
canavan disease
|
[NCBI]
|
2.82096e-05
|
|
|
epstein syndrome
|
[NCBI]
|
2.82096e-05
|
|
|
CVID
|
[NCBI]
|
2.76759e-05
|
|
|
coproporphyria
|
[NCBI]
|
2.71749e-05
|
|
|
DHFR
|
[NCBI]
|
2.66732e-05
|
|
|
GATA1
|
[NCBI]
|
2.64697e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
2.60604e-05
|
|
|
PHA2
|
[NCBI]
|
2.60604e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
2.60604e-05
|
|
|
BFH
|
[NCBI]
|
2.60604e-05
|
|
|
sitosterolemia
|
[NCBI]
|
2.60604e-05
|
|
|
CAST
|
[NCBI]
|
2.55922e-05
|
|
|
UROS
|
[NCBI]
|
2.55922e-05
|
|
|
SORD
|
[NCBI]
|
2.55922e-05
|
|
|
CD151
|
[NCBI]
|
2.55922e-05
|
|
|
LU
|
[NCBI]
|
2.55922e-05
|
|
|
XG
|
[NCBI]
|
2.55922e-05
|
|
|
HBG1
|
[NCBI]
|
2.51434e-05
|
|
|
GC
|
[NCBI]
|
2.45185e-05
|
|
|
FMF
|
[NCBI]
|
2.44935e-05
|
|
|
ADSL
|
[NCBI]
|
2.43111e-05
|
|
|
PTS
|
[NCBI]
|
2.43111e-05
|
|
|
FBS
|
[NCBI]
|
2.41268e-05
|
|
|
dent disease 1
|
[NCBI]
|
2.41268e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
2.41268e-05
|
|
|
HGPS
|
[NCBI]
|
2.35554e-05
|
|
|
AHCY
|
[NCBI]
|
2.31507e-05
|
|
|
MPO
|
[NCBI]
|
2.29281e-05
|
|
|
GAPDH
|
[NCBI]
|
2.25275e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
2.23753e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
2.23753e-05
|
|
|
HOKPP
|
[NCBI]
|
2.23753e-05
|
|
|
BLM
|
[NCBI]
|
2.19507e-05
|
|
|
ALS1
|
[NCBI]
|
2.19507e-05
|
|
|
GTS
|
[NCBI]
|
2.17953e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
2.17953e-05
|
|
|
alkaline phosphatase, elevated serum
|
[NCBI]
|
2.12557e-05
|
|
|
RUVBL2
|
[NCBI]
|
2.12557e-05
|
|
|
TKTL1
|
[NCBI]
|
2.12557e-05
|
|
|
ACYP2
|
[NCBI]
|
2.12557e-05
|
|
|
UAP1
|
[NCBI]
|
2.12557e-05
|
|
|
FEA
|
[NCBI]
|
2.12557e-05
|
|
|
PYCR1
|
[NCBI]
|
2.12557e-05
|
|
|
CD97
|
[NCBI]
|
2.12557e-05
|
|
|
RHD
|
[NCBI]
|
2.11178e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
2.078e-05
|
|
|
FCAS
|
[NCBI]
|
2.078e-05
|
|
|
EPB42
|
[NCBI]
|
1.93835e-05
|
|
|
GSTM1
|
[NCBI]
|
1.93835e-05
|
|
|
MAOB
|
[NCBI]
|
1.93835e-05
|
|
|
MCP
|
[NCBI]
|
1.92775e-05
|
|
|
SLC16A1
|
[NCBI]
|
1.84972e-05
|
|
|
SLS
|
[NCBI]
|
1.83707e-05
|
|
|
ARVD1
|
[NCBI]
|
1.79781e-05
|
|
|
SN
|
[NCBI]
|
1.7877e-05
|
|
|
BLVRB
|
[NCBI]
|
1.75834e-05
|
|
|
MPST
|
[NCBI]
|
1.75834e-05
|
|
|
PIP5K2A
|
[NCBI]
|
1.75834e-05
|
|
|
fructosamine 3-kinase
|
[NCBI]
|
1.75834e-05
|
|
|
GCNT1
|
[NCBI]
|
1.75834e-05
|
|
|
GNPI
|
[NCBI]
|
1.75834e-05
|
|
|
IHG
|
[NCBI]
|
1.75834e-05
|
|
|
STEAP3
|
[NCBI]
|
1.75834e-05
|
|
|
fructosamine 3-kinase-related protein
|
[NCBI]
|
1.75834e-05
|
|
|
FACL6
|
[NCBI]
|
1.75834e-05
|
|
|
VPS13A
|
[NCBI]
|
1.75834e-05
|
|
|
SIGLEC10
|
[NCBI]
|
1.75834e-05
|
|
|
PANX1
|
[NCBI]
|
1.75834e-05
|
|
|
USP14
|
[NCBI]
|
1.75834e-05
|
|
|
DPP3
|
[NCBI]
|
1.75834e-05
|
|
|
DCXR
|
[NCBI]
|
1.75834e-05
|
|
|
TTR
|
[NCBI]
|
1.71192e-05
|
|
|
refsum disease
|
[NCBI]
|
1.67407e-05
|
|
|
HNFJ
|
[NCBI]
|
1.67407e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
1.67407e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
1.67407e-05
|
|
|
RPS19
|
[NCBI]
|
1.65499e-05
|
|
|
ZS
|
[NCBI]
|
1.61193e-05
|
|
|
XDH
|
[NCBI]
|
1.58239e-05
|
|
|
WFS1
|
[NCBI]
|
1.5596e-05
|
|
|
TMOD
|
[NCBI]
|
1.5368e-05
|
|
|
ABCG8
|
[NCBI]
|
1.52322e-05
|
|
|
LIMS1
|
[NCBI]
|
1.52322e-05
|
|
|
PRDX3
|
[NCBI]
|
1.52322e-05
|
|
|
IL10RA
|
[NCBI]
|
1.52322e-05
|
|
|
ARG2
|
[NCBI]
|
1.52322e-05
|
|
|
RAP2B
|
[NCBI]
|
1.52322e-05
|
|
|
ALAS1
|
[NCBI]
|
1.52322e-05
|
|
|
SIGLEC5
|
[NCBI]
|
1.52322e-05
|
|
|
CHE2
|
[NCBI]
|
1.52322e-05
|
|
|
MYADM
|
[NCBI]
|
1.52322e-05
|
|
|
PSMC4
|
[NCBI]
|
1.52322e-05
|
|
|
HP
|
[NCBI]
|
1.42769e-05
|
|
|
CSMD1
|
[NCBI]
|
1.35085e-05
|
|
|
HOXB2
|
[NCBI]
|
1.35085e-05
|
|
|
C1QBP
|
[NCBI]
|
1.35085e-05
|
|
|
QTRT1
|
[NCBI]
|
1.35085e-05
|
|
|
ETFDH
|
[NCBI]
|
1.35085e-05
|
|
|
HK3
|
[NCBI]
|
1.35085e-05
|
|
|
DIA3
|
[NCBI]
|
1.35085e-05
|
|
|
BLVRA
|
[NCBI]
|
1.35085e-05
|
|
|
GCNT2
|
[NCBI]
|
1.35085e-05
|
|
|
ZFPM1
|
[NCBI]
|
1.35085e-05
|
|
|
NFE2
|
[NCBI]
|
1.35085e-05
|
|
|
feline leukemia virus subgroup c receptor
|
[NCBI]
|
1.35085e-05
|
|
|
CD36
|
[NCBI]
|
1.31266e-05
|
|
|
INSR
|
[NCBI]
|
1.30463e-05
|
|
|
AQP3
|
[NCBI]
|
1.28963e-05
|
|
|
IGER
|
[NCBI]
|
1.26278e-05
|
|
|
MTR
|
[NCBI]
|
1.24682e-05
|
|
|
ICAM1
|
[NCBI]
|
1.24682e-05
|
|
|
EPB49
|
[NCBI]
|
1.21544e-05
|
|
|
ENO3
|
[NCBI]
|
1.21544e-05
|
|
|
CR2
|
[NCBI]
|
1.21544e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
1.21544e-05
|
|
|
ABCB7
|
[NCBI]
|
1.21544e-05
|
|
|
MPG
|
[NCBI]
|
1.21544e-05
|
|
|
LAP3
|
[NCBI]
|
1.21544e-05
|
|
|
PEPB
|
[NCBI]
|
1.21544e-05
|
|
|
NCR3
|
[NCBI]
|
1.21544e-05
|
|
|
A4GALT
|
[NCBI]
|
1.21544e-05
|
|
|
ART4
|
[NCBI]
|
1.21544e-05
|
|
|
TALDO1
|
[NCBI]
|
1.21544e-05
|
|
|
HPA-2
|
[NCBI]
|
1.21544e-05
|
|
|
CD163
|
[NCBI]
|
1.21544e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.20946e-05
|
|
|
TFR2
|
[NCBI]
|
1.1666e-05
|
|
|
PNMT
|
[NCBI]
|
1.13075e-05
|
|
|
AT
|
[NCBI]
|
1.11456e-05
|
|
|
HBE1
|
[NCBI]
|
1.10445e-05
|
|
|
GCLC
|
[NCBI]
|
1.10445e-05
|
|
|
PTPNS1
|
[NCBI]
|
1.10445e-05
|
|
|
SLC4A2
|
[NCBI]
|
1.10445e-05
|
|
|
PSMC3
|
[NCBI]
|
1.10445e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
1.10445e-05
|
|
|
PHKB
|
[NCBI]
|
1.10445e-05
|
|
|
KCNN4
|
[NCBI]
|
1.10445e-05
|
|
|
CA3
|
[NCBI]
|
1.10445e-05
|
|
|
PRH2
|
[NCBI]
|
1.10445e-05
|
|
|
GBE1
|
[NCBI]
|
1.10445e-05
|
|
|
SGCE
|
[NCBI]
|
1.10445e-05
|
|
|
ANK3
|
[NCBI]
|
1.10445e-05
|
|
|
CLL
|
[NCBI]
|
1.09677e-05
|
|
|
TYMS
|
[NCBI]
|
1.07675e-05
|
|
|
MAP2
|
[NCBI]
|
1.06652e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.04368e-05
|
|
|
SEMA7A
|
[NCBI]
|
1.01081e-05
|
|
|
MTHFD1
|
[NCBI]
|
1.01081e-05
|
|
|
E2F4
|
[NCBI]
|
1.01081e-05
|
|
|
PGM2
|
[NCBI]
|
1.01081e-05
|
|
|
FSHB
|
[NCBI]
|
1.01081e-05
|
|
|
NME2
|
[NCBI]
|
1.01081e-05
|
|
|
JUNB
|
[NCBI]
|
1.01081e-05
|
|
|
NT5C
|
[NCBI]
|
1.01081e-05
|
|
|
PRDX2
|
[NCBI]
|
1.01081e-05
|
|
|
FUT6
|
[NCBI]
|
1.01081e-05
|
|
|
MAG
|
[NCBI]
|
9.8306e-06
|
|
|
TNFSF10
|
[NCBI]
|
9.81997e-06
|
|
|
LAG5
|
[NCBI]
|
9.30153e-06
|
|
|
SLC12A2
|
[NCBI]
|
9.30153e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
9.30153e-06
|
|
|
FUT3
|
[NCBI]
|
9.30153e-06
|
|
|
MAPK14
|
[NCBI]
|
9.02784e-06
|
|
|
HD
|
[NCBI]
|
8.99926e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
8.85394e-06
|
|
|
PEX12
|
[NCBI]
|
8.59566e-06
|
|
|
CD2
|
[NCBI]
|
8.59566e-06
|
|
|
C5
|
[NCBI]
|
8.59566e-06
|
|
|
NFE2L2
|
[NCBI]
|
8.59566e-06
|
|
|
FCGR2B
|
[NCBI]
|
7.97027e-06
|
|
|
NQO1
|
[NCBI]
|
7.97027e-06
|
|
|
APH
|
[NCBI]
|
7.97027e-06
|
|
|
SLC5A1
|
[NCBI]
|
7.97027e-06
|
|
|
GATA2
|
[NCBI]
|
7.97027e-06
|
|
|
FUT2
|
[NCBI]
|
7.97027e-06
|
|
|
PRF1
|
[NCBI]
|
7.96983e-06
|
|
|
SOD2
|
[NCBI]
|
7.69761e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
7.65276e-06
|
|
|
IL2
|
[NCBI]
|
7.58811e-06
|
|
|
IDE
|
[NCBI]
|
7.51675e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
7.49158e-06
|
|
|
CD14
|
[NCBI]
|
7.41065e-06
|
|
|
EIF2B5
|
[NCBI]
|
7.41065e-06
|
|
|
GNPAT
|
[NCBI]
|
7.41065e-06
|
|
|
C5R1
|
[NCBI]
|
7.41065e-06
|
|
|
CERK
|
[NCBI]
|
7.41065e-06
|
|
|
PF4
|
[NCBI]
|
7.17336e-06
|
|
|
DJS
|
[NCBI]
|
7.10585e-06
|
|
|
SCGF
|
[NCBI]
|
6.90579e-06
|
|
|
AL-A1
|
[NCBI]
|
6.90579e-06
|
|
|
JARID1D
|
[NCBI]
|
6.90579e-06
|
|
|
CBP
|
[NCBI]
|
6.90579e-06
|
|
|
SPR
|
[NCBI]
|
6.44725e-06
|
|
|
AQP9
|
[NCBI]
|
6.44725e-06
|
|
|
DMD
|
[NCBI]
|
6.39139e-06
|
|
|
RCDP1
|
[NCBI]
|
6.1077e-06
|
|
|
TKT
|
[NCBI]
|
6.02838e-06
|
|
|
C4B
|
[NCBI]
|
6.02838e-06
|
|
|
UBE1
|
[NCBI]
|
6.02838e-06
|
|
|
C4A
|
[NCBI]
|
6.02838e-06
|
|
|
GNAS
|
[NCBI]
|
5.67436e-06
|
|
|
SLOS
|
[NCBI]
|
5.65565e-06
|
|
|
THY1
|
[NCBI]
|
5.6439e-06
|
|
|
PPARBP
|
[NCBI]
|
5.6439e-06
|
|
|
HLA-A
|
[NCBI]
|
5.50106e-06
|
|
|
FA
|
[NCBI]
|
5.45274e-06
|
|
|
TAL1
|
[NCBI]
|
5.28948e-06
|
|
|
LTC4S
|
[NCBI]
|
5.28948e-06
|
|
|
RTS
|
[NCBI]
|
5.22406e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
5.22406e-06
|
|
|
ADH5
|
[NCBI]
|
4.96159e-06
|
|
|
PGM3
|
[NCBI]
|
4.96159e-06
|
|
|
LGALS3
|
[NCBI]
|
4.96159e-06
|
|
|
XLP1
|
[NCBI]
|
4.82094e-06
|
|
|
HPX
|
[NCBI]
|
4.65727e-06
|
|
|
BIRC5
|
[NCBI]
|
4.65727e-06
|
|
|
TFPI
|
[NCBI]
|
4.4716e-06
|
|
|
SMPD1
|
[NCBI]
|
4.37405e-06
|
|
|
GATA4
|
[NCBI]
|
4.37405e-06
|
|
|
TGM2
|
[NCBI]
|
4.37405e-06
|
|
|
SLC7A5
|
[NCBI]
|
4.37405e-06
|
|
|
MBL2
|
[NCBI]
|
4.37338e-06
|
|
|
NME1
|
[NCBI]
|
4.1098e-06
|
|
|
EPOR
|
[NCBI]
|
4.03384e-06
|
|
|
ADK
|
[NCBI]
|
3.86271e-06
|
|
|
TYRP1
|
[NCBI]
|
3.86271e-06
|
|
|
TSD
|
[NCBI]
|
3.72507e-06
|
|
|
THRA
|
[NCBI]
|
3.63124e-06
|
|
|
ADRB2
|
[NCBI]
|
3.63124e-06
|
|
|
BL
|
[NCBI]
|
3.4593e-06
|
|
|
NAT1
|
[NCBI]
|
3.41401e-06
|
|
|
CDA
|
[NCBI]
|
3.41401e-06
|
|
|
DCK
|
[NCBI]
|
3.20321e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
3.13781e-06
|
|
|
ACPP
|
[NCBI]
|
3.10151e-06
|
|
|
PPIB
|
[NCBI]
|
3.01768e-06
|
|
|
FH
|
[NCBI]
|
3.01768e-06
|
|
|
FOXO3A
|
[NCBI]
|
3.01768e-06
|
|
|
PSORS1
|
[NCBI]
|
2.85979e-06
|
|
|
CD44
|
[NCBI]
|
2.83661e-06
|
|
|
CFB
|
[NCBI]
|
2.83661e-06
|
|
|
PIGA
|
[NCBI]
|
2.83661e-06
|
|
|
RB1
|
[NCBI]
|
2.73164e-06
|
|
|
A2M
|
[NCBI]
|
2.66581e-06
|
|
|
SLC3A2
|
[NCBI]
|
2.66581e-06
|
|
|
SLC11A2
|
[NCBI]
|
2.59734e-06
|
|
|
VWS
|
[NCBI]
|
2.35478e-06
|
|
|
fucosidosis
|
[NCBI]
|
2.35215e-06
|
|
|
CHS
|
[NCBI]
|
2.33383e-06
|
|
|
APCS
|
[NCBI]
|
2.20803e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
2.20803e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
2.12621e-06
|
|
|
CTSC
|
[NCBI]
|
2.07167e-06
|
|
|
AN2
|
[NCBI]
|
1.91262e-06
|
|
|
BTK
|
[NCBI]
|
1.79835e-06
|
|
|
TIMP1
|
[NCBI]
|
1.70445e-06
|
|
|
HRG
|
[NCBI]
|
1.70445e-06
|
|
|
ALD
|
[NCBI]
|
1.61284e-06
|
|
|
DMD
|
[NCBI]
|
1.59296e-06
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
1.5278e-06
|
|
|
LPI
|
[NCBI]
|
1.5278e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.5278e-06
|
|
|
CBX5
|
[NCBI]
|
1.50718e-06
|
|
|
INHBA
|
[NCBI]
|
1.49057e-06
|
|
|
PNPLA6
|
[NCBI]
|
1.29981e-06
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
1.29835e-06
|
|
|
ASL
|
[NCBI]
|
1.20966e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
1.16508e-06
|
|
|
CREBBP
|
[NCBI]
|
1.1256e-06
|
|
|
MST1
|
[NCBI]
|
1.1256e-06
|
|
|
MB
|
[NCBI]
|
1.05647e-06
|
|
|
EIF4E
|
[NCBI]
|
1.04592e-06
|
|
|
ABCC1
|
[NCBI]
|
1.01934e-06
|
|
|
IBD1
|
[NCBI]
|
9.11418e-07
|
|
|
KITLG
|
[NCBI]
|
8.56284e-07
|
|
|
THRB
|
[NCBI]
|
8.31243e-07
|
|
|
CHH
|
[NCBI]
|
7.86297e-07
|
|
|
PSACH
|
[NCBI]
|
6.71869e-07
|
|
|
APOD
|
[NCBI]
|
6.49375e-07
|
|
|
PRKCM
|
[NCBI]
|
6.48986e-07
|
|
|
TFRC
|
[NCBI]
|
5.44343e-07
|
|
|
PLG
|
[NCBI]
|
4.99258e-07
|
|
|
asthma, susceptibility to
|
[NCBI]
|
4.73505e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.53474e-07
|
|
|
hemophilia a
|
[NCBI]
|
4.08579e-07
|
|
|
WT1
|
[NCBI]
|
4.01449e-07
|
|
|
JAK2
|
[NCBI]
|
3.9955e-07
|
|
|
ABP1
|
[NCBI]
|
3.77163e-07
|
|
|
wilson disease
|
[NCBI]
|
3.13359e-07
|
|
|
HEMB
|
[NCBI]
|
2.96375e-07
|
|
|
SLC2A2
|
[NCBI]
|
2.63769e-07
|
|
|
TBP
|
[NCBI]
|
2.3342e-07
|
|
|
ABCC2
|
[NCBI]
|
2.07905e-07
|
|
|
LBR
|
[NCBI]
|
2.0525e-07
|
|
|
NSF
|
[NCBI]
|
1.69918e-07
|
|
|
APOB
|
[NCBI]
|
1.35883e-07
|
|
|
ABCB11
|
[NCBI]
|
1.353e-07
|
|
|
STAT5A
|
[NCBI]
|
1.26664e-07
|
|
|
AGER
|
[NCBI]
|
1.26664e-07
|
|
|
DDC
|
[NCBI]
|
1.19302e-07
|
|
|
SERPINA6
|
[NCBI]
|
1.0649e-07
|
|
|
PLTP
|
[NCBI]
|
9.00239e-08
|
|
|
IFNA1
|
[NCBI]
|
7.8103e-08
|
|
|
MPZ
|
[NCBI]
|
7.8103e-08
|
|
|
PRLR
|
[NCBI]
|
7.67863e-08
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
7.67863e-08
|
|
|
ALB
|
[NCBI]
|
6.7357e-08
|
|
|
LPO
|
[NCBI]
|
1.24169e-08
|
|
|
STC1
|
[NCBI]
|
8.14116e-09
|
|
|
THPO
|
[NCBI]
|
8.14116e-09
|
|
|
IL3
|
[NCBI]
|
3.88516e-09
|
|
|
LS
|
[NCBI]
|
1.58461e-09
|
|
|
CLU
|
[NCBI]
|
1.47897e-09
|
|
|
STAT6
|
[NCBI]
|
1.47897e-09
|
|
|
HFE
|
[NCBI]
|
1.53302e-10
|
|